A First Time in Human Study of PIN201104 in Healthy Volunteers and Patients With Asthma

Summary

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of different single and repeat doses of PIN201104 in healthy volunteers and in patients with asthma.

Timeline

Start

2017-01

Primary completion

2018-01

Completion

2018-01

Outcome

Met primary endpoint

release “Primary endpoints of safety and pharmacokinetic data achieved Study C1104-001” revolobio.com ↗

Drugs

Indications